Medifast, Inc. — Q3 2021 Form 10-Q
Business context and reporting period. The filing covers the quarter and nine months ended September 30, 2021, compared with the same periods in 2020. Medifast’s OPTAVIA business sells nutrition products through a direct-to-consumer model supported by independent coaches. The company reports that 91.9% of revenue came from subscription-based meal-plan orders and approximately 98% from product sales.
Financial performance
| Metric | Q3 2021 | Q3 2020 | Nine months 2021 | Nine months 2020 |
|---|---|---|---|---|
| Revenue | $413.4 million | $271.5 million | $1,148.3 million | $669.9 million |
| Gross profit | $307.1 million | $204.0 million | $849.3 million | $498.6 million |
| Operating income | $55.2 million | $44.6 million | $169.4 million | $96.2 million |
| Net income | $42.0 million | $34.5 million | $130.0 million | $74.9 million |
| Diluted EPS | $3.56 | $2.91 | $10.98 | $6.32 |
| Gross margin | 74.3% | 75.2% | 74.0% | 74.4% |
| Operating margin | 13.3% | 16.4% | 14.8% | 14.4% |
Cash flow and liquidity. Nine-month operating cash flow was $102.0 million, down from $125.4 million. Investing activities used $17.4 million, including $22.6 million of capital expenditures; financing activities used $93.9 million, primarily for dividends and share repurchases. Cash and cash equivalents were $154.5 million at September 30, 2021, and cash plus investment securities totaled $159.9 million. Working capital was $140.1 million. Inventory rose to $129.6 million from $53.4 million at December 31, 2020.
Debt. Medifast had no borrowings under its $125 million revolving credit facility at quarter-end and reported compliance with its covenants. The facility matures in April 2026 and includes an option, subject to conditions, to increase capacity by up to $100 million. Lease obligations totaled $19.6 million, including $5.4 million current.
Material changes and drivers
- Q3 revenue increased 52.3%; nine-month revenue increased 71.4%. Management attributed growth mainly to more active earning OPTAVIA coaches and higher productivity per coach. Active earning coaches reached 61,000, up 44.9% year over year; quarterly revenue per active earning coach was $6,773 versus $6,329.
- Net income rose 21.9% in Q3 and 73.7% for the first nine months. In Q3, revenue growth was partly offset by higher operating expenses, and diluted EPS increased to $3.56 from $2.91.
- Q3 gross margin declined 90 basis points, while operating margin fell 310 basis points. Management cited promotional activity, inflation in ingredient, freight and labor costs, and increased use of co-manufacturers. SG&A also rose with commissions, employee costs, technology consulting, card fees and the return to an in-person annual convention.
- Commission expense was $182.1 million in Q3 and $500.7 million year to date. Commission expense as a share of revenue increased to 44.0% in Q3 from 42.3% and to 43.6% year to date from 42.0%.
- Inventory-related working-capital use contributed to lower operating cash flow. Capital expenditures increased to support technology and supply-chain capacity.
Outlook, risks and other notable items
- The filing provides no specific numerical earnings or revenue guidance. Management describes the model as scalable and expects continued growth, while cautioning that interim results are not necessarily indicative of full-year results.
- COVID-19 had not meaningfully disrupted the company’s supply chain or operations as of the filing, but renewed outbreaks, variants, supplier impacts and changes in consumer behavior could affect operations, cash flows and liquidity.
- Inflation and freight, labor and ingredient costs, promotional activity, demand growth and dependence on the coach-based sales model are relevant operating considerations.
- The company declared a $1.42-per-share quarterly dividend, payable November 8, 2021, and stated it intended to continue the dividend but could not assure future payments. It spent $46.0 million on share repurchases in the first nine months.
- Ordinary-course legal matters were not expected by management to have a material adverse effect, though outcomes cannot be predicted. The company reported no material changes to the risk factors in its 2020 Form 10-K.
- Disclosure controls were assessed as effective; no material changes in internal control over financial reporting were reported.
Important facts for investors to verify
- Whether coach growth, subscription retention and revenue per coach remain strong as the business scales.
- Whether product, freight and labor inflation, promotional activity and co-manufacturing continue to pressure gross margin.
- Inventory levels and conversion to cash, given the increase to $129.6 million and the associated operating cash-flow impact.
- Capital spending needs and the sustainability of dividends and repurchases relative to cash generation.
- COVID-19 and supply-chain developments, and compliance with the revolving-credit facility’s financial covenants.